Adagene (ADAG) Current Assets (2019 - 2025)
Adagene's (ADAG) quarterly Current Assets came in at $77375.2 billion in Q4 2025, down 11.85% year-on-year from $87778.0 billion in Q4 2024, and up 118376862.67% on a QoQ basis from $65.4 million in Q2 2025.
Adagene (ADAG) Current Assets (2019 - 2025) Analysis & Trends
Adagene (ADAG) has 7 years of Current Assets data on file, last reported at $77375.2 billion in Q4 2025.
- On a quarterly basis, Current Assets fell 11.85% year-over-year to $77375.2 billion in Q4 2025; TTM through Dec 2025 was $77375.2 billion, a 11.85% decrease from a year earlier, with the FY2025 full-year figure at $77375.2 billion, down 11.85% from the prior year.
- Current Assets for Q4 2025 stood at $77375.2 billion, up from $65.4 million in the prior quarter.
- Over the last five years, Current Assets for ADAG reached as high as $175012.9 billion in Q2 2022 and fell as low as $65.4 million in Q2 2025.
- Historically, Current Assets has averaged $73560.4 billion across 5 years, with a median of $82576.6 billion in 2024.
- Across the five-year window, Current Assets surged 81322129.11% in 2022 and sank 100.0% in 2024, its largest moves.
- Year by year, Current Assets stood at $186.0 million in 2021, then soared by 80296944.59% to $149315.4 billion in 2022, then declined by 24.02% to $113443.7 billion in 2023, then dropped by 22.62% to $87778.0 billion in 2024, then dropped by 11.85% to $77375.2 billion in 2025.
- Per Business Quant data, the three most recent Current Assets figures were $77375.2 billion in Q4 2025, $65.4 million in Q2 2025, and $87778.0 billion in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 289.93 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 73.04 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 6.60 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 35.73 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 11.73 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 18.21 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 521.86 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 8.07 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 1.97 Bn |
| 10 | Adagene | 198.85 Mn | 198.85 Mn | - | 77,375.17 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 77,375.17 Bn |
| Jun 30, 2025 | 65.36 Mn |
| Dec 31, 2024 | 87,778.01 Bn |
| Jun 30, 2024 | 98.80 Mn |
| Dec 31, 2023 | 113,443.73 Bn |
| Jun 30, 2023 | 132,678.62 Bn |
| Dec 31, 2022 | 149,315.43 Bn |
| Jun 30, 2022 | 175,012.85 Bn |
| Dec 31, 2021 | 185.95 Mn |
| Jun 30, 2021 | 215.21 Mn |
| Dec 31, 2020 | 79.10 Mn |
| Dec 31, 2019 | 103.92 Mn |